Cargando…
Small-Molecule Inhibitors Overcome Epigenetic Reprogramming for Cancer Therapy
Cancer treatment is a significant challenge for the global health system, although various pharmacological and therapeutic discoveries have been made. It has been widely established that cancer is associated with epigenetic modification, which is reversible and becomes an attractive target for drug...
Autores principales: | Xiao, Wenjing, Zhou, Qiaodan, Wen, Xudong, Wang, Rui, Liu, Ruijie, Wang, Tingting, Shi, Jianyou, Hu, Yonghe, Hou, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484527/ https://www.ncbi.nlm.nih.gov/pubmed/34603017 http://dx.doi.org/10.3389/fphar.2021.702360 |
Ejemplares similares
-
Advances of the small molecule drugs regulating fibroblast-like synovial proliferation for rheumatoid arthritis
por: Tong, Yitong, et al.
Publicado: (2023) -
Small Molecule Inhibitors of CRM1
por: Ferreira, Bibiana I., et al.
Publicado: (2020) -
Novel Regulatory Factors and Small-Molecule Inhibitors of FGFR4 in Cancer
por: Liu, Yanan, et al.
Publicado: (2021) -
ACSL4 as a Potential Target and Biomarker for Anticancer: From Molecular Mechanisms to Clinical Therapeutics
por: Hou, Jun, et al.
Publicado: (2022) -
Discovery and development of Factor Xa inhibitors (2015–2022)
por: Zheng, Wei, et al.
Publicado: (2023)